The Food and Drug Administration is seeking pilot participants to test electronic submission of non-clinical study data using a new standard.

The FDA Center for Biologics Evaluation and Research worked with the Clinical Data Interchange Standards Consortium to develop the Standard for Exchange of Non-clinical Data, or SEND. “The pilot program is intended to provide industry and CBER regulatory review staff the opportunity to evaluate SEND and determine if it facilitates the submission process of non-clinical study data related to investigational new drug applications,” according to a notice published Feb. 29.

CBER recently adopted a standard for clinical study data. Companies developing biological products also submit non-clinical data from animal studies in support of applications for approval of human drugs.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access